Avanos Medical Launches Innovative Feeding Tube System to Combat 63% Failure Rate | AVNS Stock News

Avanos Medical (NYSE: AVNS) has launched its new CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, expanding its Enteral Feeding portfolio. The system features a monofilament thread and is

Avanos Medical (NYSE: AVNS) has launched its new CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, expanding its Enteral Feeding portfolio. The system features a monofilament thread and is designed to reduce feeding tube dislodgement, which occurs in 40%-63% of tape-secured tubes. Key features include a yellow-tipped retrieval catheter with hollow tip, color-coded clips, printed centimeter markings, and an orange opening tool. The nasal bridle solution aims to improve tube survival rates and reduce complications associated with tube replacement.

Avanos Medical (NYSE: AVNS) ha lanciato il suo nuovo CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, ampliando il suo portafoglio di alimentazione enterale. Il sistema è dotato di un filo monofilamento ed è progettato per ridurre la dislocazione dei tubi di alimentazione, che si verifica nel 40%-63% dei tubi fissati con nastro. Le caratteristiche principali includono un catetere di recupero con punta cava di colore giallo, clip codificate a colori, segni in centimetri stampati e uno strumento di apertura arancione. La soluzione con briglia nasale mira a migliorare i tassi di sopravvivenza del tubo e ridurre le complicazioni associate alla sostituzione del tubo.

Avanos Medical (NYSE: AVNS) ha lanzado su nuevo Sistema de Retención de Tubo Nasogástrico/Nasointestinal CORGRIP SR, ampliando su cartera de alimentación enteral. El sistema cuenta con un hilo monofilamento y está diseñado para reducir el desplazamiento de los tubos de alimentación, que ocurre en el 40%-63% de los tubos asegurados con cinta. Las características clave incluyen un catéter de recuperación con punta hueca de color amarillo, clips codificados por colores, marcas en centímetros impresas y una herramienta de apertura de color naranja. La solución de brida nasal tiene como objetivo mejorar las tasas de supervivencia del tubo y reducir las complicaciones asociadas con el reemplazo del tubo.

Avanos Medical (NYSE: AVNS)는 새로운 CORGRIP SR 비위관/내장관 유지 시스템을 출시하여 장기간 영양 공급 포트폴리오를 확장했습니다. 이 시스템은 모노필라멘트 실을 특징으로 하며, 테이프 고정 튜브의 40%-63%에서 발생하는 튜브의 이탈을 줄이기 위해 설계되었습니다. 주요 기능으로는 중공 팁을 가진 노란색 팁의 회수 카테터, 색상으로 코딩된 클립, 인쇄된 센티미터 마킹, 주황색 개방 도구가 있습니다. 비강 브리들 솔루션은 튜브 생존율을 개선하고 튜브 교체와 관련된 합병증을 줄이는 것을 목표로 합니다.

Avanos Medical (NYSE: AVNS) a lancé son nouveau Système de Rétention de Tube Nasogastrique/Nasointestinal CORGRIP SR, élargissant son portefeuille d'alimentation entérale. Le système est doté d'un fil monofilament et est conçu pour réduire le déplacement des tubes d'alimentation, qui se produit dans 40%-63% des tubes fixés avec du ruban adhésif. Les caractéristiques clés incluent un cathéter de récupération à pointe creuse de couleur jaune, des clips codés par couleur, des marquages en centimètres imprimés et un outil d'ouverture orange. La solution de bride nasale vise à améliorer les taux de survie des tubes et à réduire les complications associées au remplacement des tubes.

Avanos Medical (NYSE: AVNS) hat sein neues CORGRIP SR Nasogastric/Nasointestinal Tube Retention System eingeführt und erweitert damit sein Portfolio für enterale Ernährung. Das System verfügt über einen Monofilamentfaden und wurde entwickelt, um die Verlagerung von Ernährungsschläuchen zu reduzieren, die bei 40%-63% der mit Klebeband gesicherten Schläuche auftritt. Zu den Hauptmerkmalen gehören ein gelbspitziger Rückholkatheter mit hohlem Ende, farbcodierte Clips, gedruckte Zentimeter-Markierungen und ein orangefarbenes Öffnungstool. Die nasale Halte-Lösung zielt darauf ab, die Überlebensraten der Schläuche zu verbessern und Komplikationen, die mit dem Austausch der Schläuche verbunden sind, zu reduzieren.

The launch of CORGRIP SR represents an incremental product improvement in Avanos Medical's enteral feeding portfolio, addressing a significant clinical need in feeding tube retention. With 40-63% of tape-secured feeding tubes becoming dislodged, this product targets a real healthcare challenge.

However, while the product offers technical improvements like enhanced visibility and better design features, its financial impact is likely to be modest. The enteral feeding segment represents a smaller portion of Avanos' revenue stream and this product is an iteration rather than a revolutionary advancement. The market for nasogastric tube retention systems is relatively niche, though stable with consistent demand from healthcare facilities.

The product's success will depend on adoption rates in healthcare settings and its pricing strategy against existing solutions. While it addresses a clinical need, the immediate financial impact on Avanos' $881M market cap is expected to be minimal.

Advancement to reduce dislodgement in feeding tube retention systems

ALPHARETTA, Ga., Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, further expanding its comprehensive Enteral Feeding portfolio.

The new CORGRIP SR system, featuring a monofilament thread, is a nasal bridle solution designed to offer numerous advantages over tape. CORGRIP SR is designed to reduce the risk of dislodgement and the complications associated with replacement of nasal tubes.

CORGRIP SR also enhances visibility and flexibility. The product includes several new features, such as a yellow tipped retrieval catheter with a hollow tip, color-coded clips, printed centimeter markings and a unique orange opening tool.

"Research shows that 40%-63% of feeding tubes secured with tape become inadvertently dislodged," says Kerr Holbrook, chief commercial officer. "Using a bridle to secure feeding tubes significantly reduces the incidence of accidental tube removal and improves overall tube survival rates."

Healthcare professionals interested in learning more about CORGRIP SR or scheduling an onsite demonstration are encouraged to visit https://avanosmedicaldevices.com/digestive-health/enteral-feeding/corgrip-sr/

About Avanos Medical, Inc.Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple categories across its portfolio. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-launches-new-corgrip-sr-302296290.html

SOURCE Avanos Medical

Nitrile Gloves Market Expected to Reach 11.31 Bn by 2032 at Growing CAGR at 10.60% | Introspective Market Research

Adhesive coatings can prevent scarring around medical implants | MIT News | Massachusetts Institute of Technology